Status:
COMPLETED
Comparing Two Devices of Uterine Manipulation and Vaginal Fornix Delineation at Total Laparoscopic Hysterectomy
Lead Sponsor:
Unity Health Toronto
Conditions:
Laparoscopic Hysterectomy for Benign Conditions
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
We hypothesize, that the use of the Hohl manipulator® at total laparoscopic hysterectomy reduces operative time (from skin incision to detachment of the uterus) and lateral termal damage of the vagina...
Eligibility Criteria
Inclusion
- All women aged over 18 years, scheduled for a laparoscopic hysterectomy for a benign disorder will be asked to participate and included after written informed consent.
Exclusion
- pregnancy
- malignancy
- if uterine size exceeds 20 weeks of gestation
- or if the uterus could be removed by a vaginal approach
Key Trial Info
Start Date :
February 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT02197728
Start Date
February 1 2014
End Date
December 1 2015
Last Update
February 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Michael´s Hospital
Toronto, Ontario, Canada, M5B 1W8